Betahydroxythiofentanyl

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Betahydroxythiofentanyl
Betahydroxythiofentanyl.svg
Systematic (IUPAC) name
N-{1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl}-N-phenylpropanamide
Clinical data
Legal status Schedule I (CA) Class A (UK) Schedule I (US)
Identifiers
CAS number 1474-34-6
ATC code None
PubChem CID 62278
ChemSpider 21106268 YesY
Synonyms β-hydroxythiofentanyl
Chemical data
Formula C20H26N2O2S 
Mol. mass 358.498 g/mol
 YesY (what is this?)  (verify)

β-hydroxythiofentanyl is an opioid analgesic that is an analogue of fentanyl.

β-hydroxythiofentanyl was sold briefly on the black market in the early 1980s, before the introduction of the Federal Analog Act which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared. [1] β-hydroxythiofentanyl was anecdotally said to be one of the more favored fentanyl analogues by opiate addicts, but nevertheless its brief career as a street drug did not survive the introduction of the Analogues Act.

β-hydroxythiofentanyl has similar effects to fentanyl. Side effects of fentanyl analogues are similar to those of fentanyl itself, which include itching, nausea, and respiratory depression, which can be serious and even life-threatening.

References[edit]

  1. ^ Henderson GL. Designer Drugs: Past History and Future Prospects. Journal of Forensic Sciences 1988; 33(2):569-575